FluroTech Ltd. (FLURF) Stock
FluroTech Ltd. operates as a technology and marketing firm, primarily focused on advancing and commercializing various innovations within the pandemic defense industry.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About FluroTech Ltd.
FluroTech Ltd. operates as a technology and marketing firm, primarily focused on advancing and commercializing various innovations within the pandemic defense industry. The company is responsible for developing the FluroTest SARS-CoV-2 diagnostic, which is designed to pinpoint patients with active viral infections. Its headquarters are located in Calgary, Canada.
FluroTech Ltd. (FLURF) stock trades at $0.00 with a market capitalization of $447175. The stock is valued at a price-to-earnings (P/E) ratio of -2.34, price-to-book of -1.41, price-to-sales of 0.00.
On profitability, FluroTech Ltd. generates a return on equity (ROE) of 80.08% — well above the market average, a sign of a high-quality business, return on capital employed of 79.85%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.flurotech.com